Background: Female sexual dysfunction (FSD) comprises genitopelvic pain and issues with female arousal and sexual interest include penetration disorder, preceding hypoactive sexual desire problem, female orgasmic disorder, and sexual dysfunction brought on by drugs or alcohol. With an estimated 20–40% frequency among women, these illnesses are very prevalent. Objective: As obstetricians and gynecologists, it is our duty to recognize conduct examinations for female sexual dysfunction and identify risk factors. It is possible to investigate sexual function and dysfunction further with appropriate screening, which finally leads to the identification of any associated suffering. The underlying problem is frequently addressed during treatment through therapy or medicinal control. Methods: PubMed, Google Scholar, and Science Direct were scoured for information on Female sexual dysfunction (drugs or alcohol), Sexual desire problem, and Management. The authors also reviewed the relevant literature, however only the most recent or comprehensive studies from December 2003 to January 2020 were included. Documents written in languages other than English have been disregarded because translation resources are inadequate. Unpublished articles, oral presentations, conference abstracts, and dissertations were not included because they were not considered to be part of major scientific projects. Conclusion: The most common forms of treatment include cognitive behavioral therapy, sometimes with a mindfulness component, and consideration of medication management are effective treatments for female sexual desire and arousal issue. Counseling, instruction, and public awareness campaigns are all part of the female orgasmic dysfunction therapy. For the treatment of penetration and genito-pelvic discomfort dysfunction, it is crucial to evaluate the underlying causes of these conditions. Last but not least, the best way to treat sexual dysfunction brought on by drugs or alcohol is to stop using the substance in question and, if the disorder is brought on by antidepressants, to think about supplementary therapy. In clinical practice, female sexual dysfunction is frequently disregarded, yet effective medical and psychosocial treatments are available.